Shareholders’ Equity - Schedule of Warrants Activity (Details) - Warrant - USD ($) $ / shares in Units, $ in Thousands |
6 Months Ended | 12 Months Ended |
---|---|---|
Jun. 30, 2025 |
Dec. 31, 2024 |
|
Number of Shares | ||
Beginning balance (in shares) | 166,670 | |
Forfeited or expired (in shares) | (3) | |
Ending balance (in shares) | 166,667 | 166,670 |
Weighted Average Exercise Price | ||
Beginning balance (in usd per share) | $ 17.40 | |
Forfeited or expired (in usd per share) | 133,500 | |
Ending balance (in usd per share) | $ 15.00 | $ 17.40 |
Total Intrinsic Value | $ 0 | $ 0 |
Weighted Average Remaining Contractual Life (Years) | 7 years 1 month 6 days | 7 years 7 months 6 days |
X | ||||||||||
- Definition Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations in Period, Weighted Average Exercise Price No definition available.
|
X | ||||||||||
- Definition Weighted Average Exercise Price. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Details
|